Home > Boards > US OTC > Miscellaneous >

Marathon Group Corporation. (PDPR)

PDPR RSS Feed
Add PDPR Price Alert      Hide Sticky   Hide Intro
Moderator: flaflyersfan, TradeForProfits
Search This Board: 
Last Post: 10/16/2019 3:55:57 PM - Followers: 172 - Board type: Free - Posts Today: 4





 

MarathonRx is a wholly owned subsidiary of Marathon Group Corp. (OTC: PDPR), formed to explore the various opportunities that are available in the booming legal cannabis industry.  As the regulatory landscape continues to evolve for cannabis products and services, MarathonRx will leverage its parent company’s proven expertise in point-of-sale solutions, digital marketing, e-commerce, advertising and lead generation.
MarathonRx’s mission is to deliver the highest quality products and services to capture a piece of an industry that is projected to be worth over $100 billion by 2025 in the US and $146 billion worldwide. The company is actively seeking suppliers, partners and acquisitions in the legal cannabis industry.










 

BREAKING NEWS!  PDPR ENTERS THE RAPIDLY GROWING CBD INDUSTRY!
 








 

Marathon Group Corp. (OTC: PDPR) Has Retained Rage Marketing, Inc. For Strategic Growth Counseling

Waterbury, CT, Feb. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Marathon Group Corp. (PDPR) (the “Company” or “Marathon”) and its subsidiary MarathonRx, Inc. are pleased to announce they have retained Rage Marketing, Inc. (RMI), a cutting-edge marketing firm specializing in small-cap and micro-cap companies trading on the OTC Markets, as their strategic growth consultant. 

Under the terms of the agreement, RMI will expand Marathon Group’s presence with the nation’s brokerage and investment community, manage its growing shareholder base, develop and implement the Company’s overall corporate communications strategy.

Rage Marketing will also tap into its CBD industry network to assist with product development, identifying top quality suppliers and brand awareness.

“The addition of Rage Marketing solidifies our goal to aggressively take our share of the booming CBD industry,” states MacDonald Tudeme, President and CEO of Marathon Group. “Their expertise in business development and investor relations will assist us in building MarathonRx from the ground level to revenue generating in a short time,” he continued.

About MarathonRx, Inc.

MarathonRx is a wholly owned subsidiary of Marathon Group Corp. (PDPR), formed to explore the various opportunities that are available in the booming legal cannabis industry.  As the regulatory landscape continues to evolve for cannabis products and services, MarathonRx will leverage its parent company’s proven expertise in point-of-sale solutions, digital marketing, e-commerce, advertising and lead generation.

About Marathon Group Corp

Marathon Group Corp. (PDPR) is a Connecticut-based software company engaged in web property development, focused on solving problems faced by small and medium size businesses.

About Rage Marketing, Inc.

Rage Marketing Inc. is a cutting-edge marketing firm focused on Small-cap and Micro-cap companies trading on the OTC Markets. We are passionate about helping undervalued companies reach the audience they deserve. We know market trends. We are informed about the regulatory landscape. It's our business to understand the mindset of today's investors and how to deliver our clients’ message.

Safe Harbor Statement
The matters discussed, particularly information regarding future revenue, earnings, business plans and goals, consist of forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are subject to the safe harbor created by these sections and involve risks and uncertainties, which could cause actual results to differ materially from the forward-looking information. Such statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. These statements are based on assumptions and estimates that management believes are reasonable based on currently available information; however, management’s assumptions and the Company’s future performance are both subject to a wide range of business risks and uncertainties, and there is no assurance that these goals and projections can or will be met. Any number of factors could cause actual results to differ materially. The Company undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking information contained herein is subject to the risk factors and uncertainties described in the Company’s filings with the Securities and Exchange Commission, which risk factors and uncertainties are incorporated by reference as though fully set forth herein.

http://globalfinance.zenfs.com/en_us/finance/us_aftp_globenewswire_emailnotif_live/ti?nf="NzUwMzc1OCMyNzM0NTQ0IzUwMDA1MjY2Mw==" "="" rel="nofollow" target="_blank">http://globalfinance.zenfs.com/en_us/Finance/US_AFTP_GlobeNewsWire_EmailNotif_LIVE/ti?nf=NzUwMzc1OCMyNzM0NTQ0IzUwMDA1MjY2Mw=="; style="border-style:none; bottom:0px; height:1px; left:0px; position:absolute; right:0px; top:0px; transition-duration:0.42s; vertical-align:bottom; width:1px">

MacDonald Tudeme

jasmactt@gmail.com

Investor Relations:

 

Rage Marketing Inc.

info@ragemarketinginc.com

(800) 867-1851



 

MarathonRx’s mission is to deliver the highest quality products and services to
capture a piece of an industry that is projected to be worth over
$100 billion by 2025 in the US and $146 billion worldwide.

 


CBD 1,500 mg/oz drops
Marathon Group's Wholly Owned Subsidiary, MarathonRx, Has Signed a Manufacturing and Supply Agreement for a 1,500mg Nano-Pure Ultra CBD Drops Product, the First of Many Products (2/15/19)
https://finance.yahoo.com/news/marathon-groups-wholly-owned-subsidiary-211000958.html

A TechNavio report (https://www.technavio.com/report/global-cbd-oil-market-analysis-share-2018) indicates the CBD oil market is expected to grow by 31% year over year through 2022.

 A search on 
https://www.ncbi.nlm.nih.gov/pubmed/?term=cbd+oil for the term 'CBD oil' brings up a number of studies regarding the widespread benefits of CBD oil use.




 
CBD is readily obtainable in most parts of the United States, though its exact legal status is in flux. All 50 states have laws legalizing CBD with varying degrees of restriction, and while the federal government still considers CBD in the same class as marijuana, it doesn’t habitually enforce against it. 
Studies show - when treating some of the cruelest childhood epilepsy syndromes -  CBD was able to reduce the number of seizures, and in some cases it was able to stop them altogether. 





 

CBD has been shown to treat CHRONIC PAIN and ARTHRITIS 
 





 
CBD may offer an option for treating different types of chronic pain. A study from the European Journal of Pain showed, using an animal model, CBD applied on the skin could help lower pain and inflammation due to arthritis. 
Another study demonstrated the mechanism by which CBD inhibits inflammatory and neuropathic pain, two of the most difficult types of chronic pain to treat. 






 

CBD has been shown to treat ALZHEIMER's and MULTIPLE SCLEROSIS
 






 

Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.

Several studies have demonstrated the therapeutic potential of cannabis and its derivate products to manage the symptoms of multiple sclerosis (MS) and other neurodegenerative diseases.








 


MarathonRx has laid the groundwork for a rapid move into the CBD field.
Discussions are already underway with various labs and suppliers
of top quality CBD products.






 









 



THE US CBD PRODUCT MARKET IS EXPANDING!!!!!!!!!



Image result for projected CBD market



 



You can stay up to date with our progress by visiting our website: 

 http://www.marathonrx.com 

and subscribing to our newsletter for updates.

 
PDPR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#11650  Sticky Note $PDPR CBD 'Signed a Manufacturing and Supply Agreement' TradeForProfits 02/22/19 09:13:40 AM
#14353   Oracle, No disrespect, i would like to have a thetinman 10/16/19 03:55:57 PM
#14352   Wow, a ton of products online for PDPR? thetinman 10/16/19 11:12:04 AM
#14351   Oracle, thetinman 10/16/19 11:10:17 AM
#14350   With all this silence from PDPR why is thetinman 10/16/19 10:22:00 AM
#14349   PDPR has NO links to website marketing? thetinman 10/15/19 06:25:49 PM
#14348   Still waiting for link to PDPR marketing their thetinman 10/15/19 09:55:52 AM
#14346   wwj, ONLY 47k to get into the .0002's here thetinman 10/14/19 02:04:04 PM
#14344   Is it like one of those pictures you wwj 10/14/19 01:43:49 PM
#14342   I thought maybe charting skills would help move thetinman 10/14/19 01:08:02 PM
#14341   if you stare at level2 some longer it RammageRaul 10/14/19 01:02:55 PM
#14340  Restored Still 47k on CRYO bid and ask.. Start thetinman 10/14/19 11:39:12 AM
#14339   PDPR can not get any worse... has anyone thetinman 10/14/19 11:33:26 AM
#14337   Disregarding the other hand and looking on the wwj 10/14/19 11:28:27 AM
#14336   Only lose when selling, that's right - oh wwj 10/14/19 11:19:16 AM
#14334   Maybe PDPR will have news / bid next month? thetinman 10/14/19 10:24:32 AM
#14333   whoo hoo BIG volume of 220.00 dollars traded thetinman 10/11/19 12:41:16 PM
#14332   nope only 47K grand RammageRaul 10/11/19 10:02:06 AM
#14331   Go early, RRaul, the line's pretty long. Oracle 10/10/19 06:59:53 PM
#14330   Only about a Billion Shares on the Ask Big Arlen Van Black 10/10/19 02:26:06 PM
#14329   I wonder why PDPR's MFG for reselling CBD thetinman 10/10/19 10:24:43 AM
#14327   in pinkyland you only lose a trade when RammageRaul 10/10/19 09:57:46 AM
#14323   cant add more or will have to file RammageRaul 10/10/19 09:32:44 AM
#14321   only 2 1/2 months left :) RammageRaul 10/10/19 09:12:51 AM
#14320   LMAO at PDPR and 1000% in 2020 !! thetinman 10/10/19 08:58:45 AM
#14319   those 1s will be worth $$ 1000% $$ RammageRaul 10/10/19 08:56:30 AM
#14318   LMAO on not a PDPR p & d? thetinman 10/10/19 08:43:15 AM
#14317   this is not a p & d RammageRaul 10/10/19 08:36:31 AM
#14316   PDPR needs to help themselves " 1-22-19 announce thetinman 10/09/19 11:40:47 AM
#14315   Oracle, Please post your private message you sent me thetinman 10/09/19 11:06:40 AM
#14314   ty wwj for the timelines !! I wonder thetinman 10/08/19 03:15:59 PM
#14313   Most recent news: wwj 10/08/19 03:13:45 PM
#14312   Oracle, Got your messages but cant respond... feel free thetinman 10/08/19 02:23:58 PM
#14311   Do you feel better now that you've had thetinman 10/08/19 09:56:09 AM
#14309   PLEASE provide a link or time period where thetinman 10/08/19 08:58:23 AM
#14308   PDPR software company? please post what software PDPR thetinman 10/08/19 08:20:25 AM
#14307   MARATHON NEWS - discussion Oracle 10/07/19 07:21:40 PM
#14306   BIG PDPR volume $350.00 today!! thetinman 10/07/19 04:37:35 PM
#14305   NOBODY WANTS PDPR for THIN if any PROFITS? thetinman 10/07/19 09:53:48 AM
#14304   PDPR bid / ask keeps GROWING.. thetinman 10/07/19 09:53:19 AM
#14303   ONLY 47k to move PDPR into the .002's.. thetinman 10/07/19 09:45:30 AM
#14302   Could PDPR / Marathon Rx just be a thetinman 10/06/19 01:32:49 PM
#14301   That's HILARIOUS that my telling the truth is thetinman 10/04/19 12:55:45 PM
#14300   awww, i see someone is back... PDPR needs thetinman 10/04/19 12:32:25 PM
#14298   ONY 47k to clear PDPR's .0001's... ask /bid thetinman 10/04/19 11:30:41 AM
#14297   Rumors has it, the profits will be THIN thetinman 10/04/19 10:27:07 AM
#14296   BIG volume this am so far with PDPR thetinman 10/04/19 10:25:18 AM
#14295   buy before the rumor lol RammageRaul 10/04/19 10:24:45 AM
#14294   Why else would you buy a stock like thetinman 10/03/19 03:30:52 PM
#14292   Look at the PDPR YTD chart NOT LOOKING thetinman 10/03/19 02:29:48 PM
#14291   Why is no one slapping PDPR ask for thetinman 10/03/19 09:34:27 AM
PostSubject